NIAID VIROLOGY QUALITY ASSURANCE (VQA)
- Institution
- Duke University, NC
- Principal investigator
- Thomas Denny
- Funding
- $3.4M
- Duration
- 2025–2026
Moonbase score
Still being scored
Abstract
The purpose of the NIAID Virology Quality Assurance (VQA) program is to provide a comprehensive quality assessment program for virologic assays for HIV, and other viral pathogens, performed on samples from subjects enrolled in NIAID-sponsored multisite clinical studies. The VQA program ensures the validity and inter- and intra-laboratory comparability of virologic laboratory data obtained from NIAID-supported clinical trials and HIV natural history studies by providing laboratories with proficiency testing panels and real-time assay run controls and analyzing proficiency panel and assay run data from each laboratory. The VQA program also implements standards of performance for existing and state-of-the-art new virologic assays, develops and tests biostatistical methods relating to the assays, and acquires, tests, stores and dispenses quality control materials and reagents.
LOADING MOONBASE SCORE
Questions for Duke University
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Duke UniversityNot yet scored
Collaborative Influenza Vaccine Innovation Centers (CIVICs): Component B: Vaccine Manufacturing and Toxicology Core
Thomas Denny · $529K · 2019–2028
- NIH · Duke University62
Functional connectivity of a brain-scale neural circuit for motion perception
Eva Aimable Naumann · $561K · 2022–2027
- NSF · Duke University61
Risk Factor Analysis and Dynamic Response for Epidemics in Heterogeneous Populations
Thomas Barthel · $500K · 2024–2027